Rami Yaka Selected Research

Rami Yaka Research Topics

3	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2010 - 07/2007
2	Substance-Related Disorders (Drug Abuse) 05/2022 - 02/2012
2	Neuroinflammatory Diseases 09/2016 - 07/2011
2	Wounds and Injuries (Trauma) 09/2016 - 08/2008
1	Channelopathies 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Prodromal Symptoms 01/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2017
1	Stroke (Strokes) 09/2016
1	Ischemia 09/2016
1	Memory Disorders (Memory Loss) 09/2016
1	Shock 02/2012
1	Nervous System Diseases (Neurological Disorders) 11/2010
1	Skin Manifestations 05/2010
1	Infarction (Infarctions) 03/2010
1	Brain Injuries (Brain Injury) 03/2010
1	Closed Head Injuries 07/2007
1	Alcoholism (Alcohol Abuse) 05/2003
1	Glioma (Gliomas) 08/2002

5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2016 - 05/2003
3	N-Methylaspartate (NMDA)IBA 09/2016 - 07/2007
3	Cycloserine (Seromycin)FDA Link 09/2016 - 07/2007
3	Cocaine (Cocaine HCl)IBA 02/2012 - 05/2010
2	EndotoxinsIBA 09/2016 - 07/2011
2	Glutamic Acid (Glutamate)FDA Link 08/2008 - 07/2007
1	EndocannabinoidsIBA 05/2022
1	SynucleinsIBA 01/2021
1	tempolIBA 11/2017
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 11/2017
1	Pharmaceutical PreparationsIBA 02/2012
1	Sucrose (Saccharose)IBA 02/2012
1	PK 11195 (PK11195)IBA 07/2011
1	triphenyltetrazoliumIBA 03/2010
1	cresyl violetIBA 03/2010
1	src-Family KinasesIBA 08/2008
1	Ethanol (Ethyl Alcohol)IBA 05/2003
1	tat Gene Products (tat Protein)IBA 08/2002

2	Therapeutics 01/2021 - 08/2008
2	Self Administration (Administration, Self) 02/2012 - 11/2010
1	Deep Brain Stimulation 11/2010
1	Neurosurgical Procedures 08/2008